Profil
Joy Yan worked as Director-Clinical Development at Bayer AG.
Dr. Yan was Director at Checkmate Pharmaceuticals, Inc. from 2021 to 2022.
Dr. Yan served as Independent Director at Moleculin Biotech, Inc. from 2022 to 2026.
Dr. Yan held the position of Chief Medical Officer at Ambrx, Inc. and Ambrx Biopharma Cayman, Inc. Dr. Yan was Chief Medical Officer at Keymed Biosciences, Inc. from 2022 to 2024.
Dr. Yan earned doctorates from The Johns Hopkins University and China Medical University.
Ehemalige bekannte Positionen von Joy Yan
| Unternehmen | Position | Ende |
|---|---|---|
| MOLECULIN BIOTECH, INC. | Direktor/Vorstandsmitglied | 10.08.2026 |
| KEYMED BIOSCIENCES INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2024 |
| CHECKMATE PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 31.05.2022 |
| BAYER AG | Corporate Officer/Principal | - |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Joy Yan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Bayer AG
Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrx, Inc.
Ambrx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
China Medical University
China Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Moleculin Biotech, Inc.
Moleculin Biotech, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of treatments for highly resistant cancers and viruses | Health Technology |
Keymed Biosciences, Inc.
Keymed Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the treatment of asthma, chronic obstructive pulmonary and other respiratory diseases | Health Technology |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Health Technology |
















